- videocam Live Online with Live Q&A
- calendar_month November 13, 2025 @ 1:00 p.m. ET./10:00 a.m. PT
- signal_cellular_alt Intermediate
- card_travel Health
- schedule 90 minutes
No Surprises Act Update: Regulatory and Litigation Developments, Ongoing Compliance Challenges for Stakeholders
Welcome! Strafford is now BARBRI! The expert courses you know from the trusted global leader in legal education.
Description
The NSA was enacted as part of the Consolidated Appropriations Act of 2021 at the end of the first Trump term and prohibits out-of-network (OON) providers from balance billing patients for certain services furnished at an OON facility (in the case of emergency services) or at an in-network facility (in the case of non-emergency services provided by an OON provider). Since its implementation, the NSA has been the subject of consistent litigation, impacting ongoing rulemaking and regulation and creating compliance challenges for stakeholders.
Some of the most notable litigation has been brought by the Texas Medical Association (TMA) in a series of lawsuits impacting regulatory guidance (TMA I, TMA II, TMA III, and TMA IV). For example, earlier this year, the U.S. Departments of Labor, Health and Human Services, and the Treasury jointly issued Part 69 of a series of FAQs designed to help stakeholders understand and comply with the NSA—this installment providing updates to disclosure and cost-sharing requirements following the TMA III decisions. Yet, despite the guidance, questions and compliance challenges remain.
Listen as our expert panel of healthcare practitioners examines recent regulatory developments and the status of noteworthy litigation surrounding the NSA. The panel will also offer best practices for compliance in this rapidly evolving regulatory landscape.
Presented By

Mr. Arters leverages a deep understanding of the issues health care entities encounter in the constantly evolving health care industry to serve providers’ business and legal objectives. He has experience representing a diverse group of health care entities, including premier-profit and not-for-profit hospital systems, hospital associations, ambulatory surgery centers, air ambulance service providers, specialty providers, national physician groups, ancillary service providers, and medical device companies. Mr. Arters’ practice focuses on managed care disputes, strategies, and litigation, which is supported by over a decade of experience assisting clients to ascertain tailored solutions to complex commercial disputes through strategic negotiation, mediation, arbitration, and litigation in state and federal courts across the U.S. He counsels clients on a broad range of commercial and managed care matters, including federal No Surprises Act compliance and operations, Administrative Procedure Act challenges, underpayments and denials, recoupments and offsets, commercial payor audits, network contracting, out-of-network reimbursement, and code-editing and down-coding policies, among other matters.

Ms. Boaz brings her analytical skills and client-focused approach to represent and advise a diverse group of health care clients, including health plans, clinical laboratories, pharmaceutical companies, pharmacy chains, telehealth providers, medical device companies, hospitals and health systems, management services organizations, and other clients. She focuses her work on regulatory due diligence, regulatory counseling, and policy and legislative analysis. Ms. Boaz walks clients through: plan and issuer-side compliance with the No Surprises Act, the Transparency in Coverage rules, and other requirements under the Consolidated Appropriations Act; provider and facility-side compliance with the No Surprises Act and state surprise and balance billing laws, particularly on matters impacting providers, facilities, and clinical laboratories; and provider and facility compliance and implementation with “Good Faith Estimate” requirements, including with the preparation of customized forms, among other matters. She also closely follows developments to keep clients up to date on surprise billing and prescription drug pricing matters, the individual marketplace, and developments in Medicare.

Mr. Mazzola focuses his practice in the areas of ERISA and managed care litigation; life, health, and disability benefit litigation; and related insurance coverage issues. He has spent much of his career litigating complicated life, health, and disability insurance related claims and disputes. Mr. Mazzola defends life, health, disability and accidental death and dismemberment claims brought in state and federal court against insurers, plan administrators, employers, benefit plans, managed care organizations, PPOs, HMOs, third party administrators, and pharmacy benefit manager, including in cases governed by ERISA, Federal Employees Health Benefits Act (FEHBA), and the Federal Employees' Group Life Insurance program. He has experience in many areas of life, health, and disability litigation, including complex health care issues involving ERISA, FEHBA and Medicare preemption, payor/provider contract disputes, nonparticipating provider reimbursement claims involving both federal and state law claims, pharmacy benefit plan/provider disputes, and behavioral health claim disputes, including claims alleging violations of federal and state Mental Health Parity and Addiction Equity laws. Mr. Mazzola manages litigation from inception through trial/arbitration, tirelessly working to obtain the most beneficial resolution for his clients. He also has written many appellate briefs for clients in the United States Court of Appeals for the Second Circuit and the New York State Appellate Divisions involving complicated legal issues in both ERISA and non-ERISA cases.
-
This 90-minute webinar is eligible in most states for 1.5 CLE credits.
-
Live Online
On Demand
Date + Time
- event
Thursday, November 13, 2025
- schedule
1:00 p.m. ET./10:00 a.m. PT
Outline
I. Introduction
II. No Surprises Act overview
A. Purpose
B. Governing regulations
C. Provider obligations
III. History and status of notable legal challenges
A. Texas Medical Association lawsuits
B. Other noteworthy litigation
C. Impact on NSA rulemaking and implementation guidance (e.g., FAQs)
IV. Regulatory update
V. Best practices for provider policy development and compliance
VI. Practitioner takeaways
Benefits
The panel will review these and other important issues:
- What is the status of noteworthy litigation surrounding the NSA?
- How has litigation, including the TMA lawsuits, impacted agency guidance related to the NSA?
- What are key regulatory updates of which counsel should be aware?
- What NSA questions and compliance challenges remain for stakeholders despite ongoing agency guidance?
Unlimited access to premium CLE courses:
- Annual access
- Available live and on-demand
- Best for attorneys and legal professionals
Unlimited access to premium CPE courses.:
- Annual access
- Available live and on-demand
- Best for CPAs and tax professionals
Unlimited access to premium CLE, CPE, Professional Skills and Practice-Ready courses.:
- Annual access
- Available live and on-demand
- Best for legal, accounting, and tax professionals
Unlimited access to Professional Skills and Practice-Ready courses:
- Annual access
- Available on-demand
- Best for new attorneys
Related Courses

No Surprises Act Update: Regulatory and Litigation Developments, Ongoing Compliance Challenges for Stakeholders
Thursday, November 13, 2025
1:00 p.m. ET./10:00 a.m. PT

Med Spa Formation, Licensure, and Operational Compliance: Navigating Complex Federal and State Regulatory Issues
Wednesday, December 3, 2025
1:00 p.m. ET./10:00 a.m. PT

Government Permit Issues in Healthcare M&A Transactions: Buyer and Seller Strategies, Compliance Challenges
Wednesday, October 22, 2025
1:00 p.m. ET./10:00 a.m. PT
Recommended Resources
Navigating Modern Legal Challenges: A Comprehensive Guide
- Business & Professional Skills
- Career Advancement